MedPal AI plc Announces October 2026 Trading Update

MedPal AI reported unaudited October 2026 group revenue of approximately £4.1 million, up from £3.2 million in September. Its New Health division generated £3.63 million, a 33% month-on-month increase, with more than 29,400 orders. Repeat-order revenue more than doubled to £1.34 million, or 37% of the division’s revenue, and has grown more than thirteen-fold since August. Group recurring revenue was approximately £1.8 million, equal to 45% of total revenue, supporting a pro forma annualised run-rate of £49 million.